0954 GMT - German life-sciences and chemicals group Merck KGaA isn't rushing for a deal to acquire another company, outgoing chief executive Belen Garijo tells Bloomberg at the World Economic Forum in Davos, Switzerland. "We are not in a hurry. It will come at the right time," she says. Merck KGaA's M&A strategy was previously aimed at building scale, but it is now more focused on securing targets that can bring innovation to its portfolio, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. Merck KGaA shares trade 1.2% lower at 127.60 euros. (mauro.orru@wsj.com)
(END) Dow Jones Newswires
January 20, 2026 04:54 ET (09:54 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.